Everett E. Vokes to Thyroid Neoplasms
This is a "connection" page, showing publications Everett E. Vokes has written about Thyroid Neoplasms.
Connection Strength
0.716
-
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer. Ann Oncol. 2023 08; 34(8):714-722.
Score: 0.657
-
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol. 2008 Oct 10; 26(29):4708-13.
Score: 0.058